Cargando…

NEDD9 overexpression predicts poor prognosis in solid cancers: a meta-analysis

Background: The oncogenicity of neural precursor cell-expressed developmentally down-regulated 9 (NEDD9) has been demonstrated in multiple cancer types. However, the prognostic value of NEDD9 in some solid cancers remains controversial. Thus, this meta-analysis was conducted to evaluate the relation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Yang, Lu, Jingjing, Chen, Chen, Zheng, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549757/ https://www.ncbi.nlm.nih.gov/pubmed/31213839 http://dx.doi.org/10.2147/OTT.S205760

Ejemplares similares

Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
por: Chen, Siying, et al.
Publicado: (2018)

Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis
por: Wang, Shengjie, et al.
Publicado: (2018)

NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis
por: Wan, Lingfeng, et al.
Publicado: (2019)

CDC20 overexpression leads to poor prognosis in solid tumors: A system review and meta-analysis
por: Wang, Shengjie, et al.
Publicado: (2018)

NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia
por: Hua, Shenghao, et al.
Publicado: (2021)

Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
por: Shen, Congcong, et al.
Publicado: (2020)

Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis
por: Wu, Jiayuan, et al.
Publicado: (2017)

The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients
por: Li, Peng, et al.
Publicado: (2016)

Overexpression of NEDD9 in renal cell carcinoma is associated with tumor migration and invasion
por: Wang, Jue, et al.
Publicado: (2017)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
por: Chen, Tzu-Ju, et al.
Publicado: (2022)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
por: Huang, Chao, et al.
Publicado: (2020)

Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer
por: Zhao, Jingkun, et al.
Publicado: (2017)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
por: Lu, Wenjie, et al.
Publicado: (2020)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation
por: Wang, Xikai, et al.
Publicado: (2021)

Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort study
por: Gu, Aiqin, et al.
Publicado: (2020)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer
por: Lin, Xiao-Lu, et al.
Publicado: (2017)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer
por: Xia, Shujing, et al.
Publicado: (2019)

Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis
por: Li, Yiming, et al.
Publicado: (2017)

The Overexpression of Scaffolding Protein NEDD9 Promotes Migration and Invasion in Cervical Cancer via Tyrosine Phosphorylated FAK and SRC
por: Sima, Ni, et al.
Publicado: (2013)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer
por: Yang, Bo, et al.
Publicado: (2014)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jiang, Jie, et al.
Publicado: (2021)

Overexpression of MUC1 predicts poor prognosis in patients with breast cancer
por: Jing, Xuan, et al.
Publicado: (2019)

Trop2 is overexpressed in gastric cancer and predicts poor prognosis
por: Zhao, Wei, et al.
Publicado: (2015)

The role of SOX2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review
por: Wang, Shengjie, et al.
Publicado: (2020)

Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
por: Le, Lulu, et al.
Publicado: (2021)

Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
por: Xian, Jingrong, et al.
Publicado: (2022)

Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma
por: Wang, Ziming, et al.
Publicado: (2020)

Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis
por: Chen, Jiewei, et al.
Publicado: (2017)

LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis
por: Zhang, Yan, et al.
Publicado: (2010)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma
por: Li, Jiangfen, et al.
Publicado: (2019)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis
por: Yuan, Chun-Ling, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_60mfjngtibjtao2kut50m7auf8